PGR network indicates that while the SilverHawk is still the market leader in the peripheral atherectomy space, physicians often choose the Diamondback over the Silverhawk, particularly in cases below-the-knee.  The SilverHawk, EVVV’s pioneering endovascular surgical device from its acquisition of FoxHollow, has been facing competition from new players in the market over the past few years, most notably from Cardiovascular Systems, Inc.’s (CSII) Diamondback 360 and Pathway Medical’s Jetstream G2.  The Jetstream does not seem to be making an impression on the market, but the SilverHawk and Diamondback continue to carve out their respective niche markets, further shifting market share.

Tweet This Post